Tags: Drug.

Ro4938581 is a nootropic drug invented in 2009 by a team working for Hoffmann-La Roche which acts as a subtype-selective inverse agonist at the α5 subtype of the benzodiazepine binding site on the GABAA receptor. It has good selectivity for the α5 subtype and did not produce convulsant or anxiogenic effects in animal studies making it a promising potential nootropic.

Ro4938581_structure.png
IUPAC name
3-bromo-10-(difluoromethyl)-9H-benzo[f]imidazo[15-a][124]triazolo[15-d][14]diazepine
PubChem
11624499

Loading...

This page contains content from the copyrighted Wikipedia article "Ro4938581"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.